Opthea Announces COAST Phase 3 Trial Topline Results
24 Mar 2025 //
GLOBENEWSWIRE
Dr. Angela Fisher to Speak at Cannadelic Miami 2025 Conference
22 Mar 2025 //
ACCESSWIRE
Feinstein Gets $3M NIH Grant For Vagus Nerve Stimulation
20 Mar 2025 //
BUSINESSWIRE
U.S. Oral Surgery Management Enters Wisconsin Market
20 Mar 2025 //
GLOBENEWSWIRE
Optum Rx Further Simplifies Consumer Access to Prescription Drugs
19 Mar 2025 //
BUSINESSWIRE
Nextech EDGE 2025: Showcasing Innovations for Specialty Practices
06 Mar 2025 //
GLOBENEWSWIRE
Sofwave Medical Reports Q4 and Full Year 2024 Financials
05 Mar 2025 //
GLOBENEWSWIRE
Health Canada Issues Recall of Jamp Pharma Corp`s JAMP Cephalexin Suspension
22 Mar 2024 //
HEALTH CANADA
Ginkgo Bioworks and Centrient Pharmaceuticals Announce Expansion of Partnership
25 May 2023 //
PRESS RELEASE
China`s Covid surge: Corona-drug associated APIs get costlier
27 Dec 2022 //
ECONOMICTIMES
Enforcement Report - Week of February 24, 2021
24 Feb 2021 //
FDA
Enforcement Report - Week of January 13, 2021
13 Jan 2021 //
FDA
Enforcement Report - Week of September 16, 2020
16 Sep 2020 //
FDA
Health Canada Issues Recall of Teva Canada`s-Cephalexin
21 Aug 2020 //
HEALTH CANADA
Enforcement Report - Week of November 13, 2019
13 Nov 2019 //
FDA
Alkem Labs Generic Cephalexin Receives Approval in US
29 Mar 2019 //
FDA
Enforcement Report - Week of February 6, 2019
06 Feb 2019 //
FDA
Enforcement Report - Week of January 23, 2019
23 Jan 2019 //
FDA
Anvisa Suspended Lots of Cephalexin
19 Jul 2016 //
ANVISA
Prohibited use of Cephalexin lot Laboratorio Teuto
01 Feb 2016 //
ANVISA
Suspended lot of Cephalexin Drug Laboratorio Teuto Brasileiro
26 Nov 2015 //
ANVISA
Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
02 May 2015 //
FIERCE PHARMA MFG